Acadian Asset Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.11M | Sell |
627,348
-3,605
| -0.6% | -$12.1K | ﹤0.01% | 814 |
|
|
2025
Q1 | $2.43M | Buy |
630,953
+63,349
| +11% | +$244K | 0.01% | 705 |
|
|
2024
Q4 | $3.5M | Sell |
567,604
-15,556
| -3% | -$96K | 0.01% | 618 |
|
|
2024
Q3 | $3.14M | Hold |
583,160
| – | – | 0.01% | 618 |
|
|
2024
Q2 | $1.95M | Buy |
583,160
+179,614
| +45% | +$601K | 0.01% | 770 |
|
|
2024
Q1 | $1.63M | Buy |
403,546
+222,805
| +123% | +$897K | 0.01% | 707 |
|
|
2023
Q4 | $478K | Buy |
+180,741
| New | +$478K | ﹤0.01% | 1035 |
|
|
2023
Q1 | – | Sell |
-57,957
| Closed | -$594K | – | 1791 |
|
|
2022
Q4 | $594K | Buy |
+57,957
| New | +$594K | ﹤0.01% | 987 |
|